Skip to content

In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome

In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00302874
Enrollment
400
Registered
2006-03-15
Start date
2003-02-28
Completion date
2004-10-31
Last updated
2007-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hyperglycemia

Keywords

diabetes, hyperglycemia, hospital, medicine ward

Brief summary

To improve glycemic control of inpatients admitted to the internal medicine wards, the researchers generated a protocol based on intensive insulin treatment for use in all inpatients with hyperglycemia. The researchers hypothesize that intensive insulin treatment will improve the glycemic control and the outcome of hospitalized patients. Study Information: * All patients with a history of diabetes admitted to the internal medicine ward were enrolled in the study. * At baseline, demographic and clinical information were obtained, including information necessary to determine the severity of the illness. Venous capillary blood glucose levels were checked 4 times a day by glucometer. * During the pre-intervention period, patients were treated according to the common practice in the hospital without any intervention. The study team collected the baseline data on the glycemic control and treatment of patients admitted with hyperglycemia. * During the intervention period, the study team visited the ward daily and guided the medical staff as to the use of the treatment protocol. * During the post-intervention period, the study team collected the data without active intervention in the implementation of the protocol. * Data was collected on the mode of treatment and glycemic control of all hyperglycemic patients throughout the study. The incidence of hypoglycemia, complications (myocardial infarction, stroke, infections), mortality, transfer to intensive care unit (ICU), length of hospitalization, and disposition at discharge were noted.

Interventions

BEHAVIORALImplementation of a protocol for treatment of hyperglycemia

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients admitted to the internal medicine ward with hyperglycemia

Exclusion criteria

* Patients admitted due to hypoglycemia, hyperosmolar state, and ketoacidosis

Design outcomes

Primary

MeasureTime frame
Mean blood glucose during hospitalization

Secondary

MeasureTime frame
Hypoglycemic events
Length of in-hospital stay
Infections
Complications (myocardial infarction, stroke)
Disposition at discharge (home, nursing home)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026